Incorporating Clinical Decisions into Standardised Caremaps by Mclachlan, S et al.
 
Incorporating Clinical Decisions into Standardised 
Caremaps 
Scott Mclachlan  
Queen Mary University of London 
London, United Kingdom 
ORCID: 0000-0002-2528-8050 
Kudakwashe Dube 
Massey University 
Palmerston North, New Zealand 
ORCID: 0000-0002-2829-8481 
Graham A Hitman 
Queen Mary University of London 
London, United Kingdom 
g.a.hitman@qmul.ac.uk 
Evangelia Kyrimi 
Queen Mary University of London 
London, United Kingdom 
0000-0001-6727-2279 
Max Marsden 
Queen Mary University of London 
London, United Kingdom 
m.e.r.marsden@qmul.ac.uk 
Norman E Fenton 
Queen Mary University of London 
London, United Kingdom 
n.fenton@qmul.ac.uk 
Bridget J Daley 
Queen Mary University of London 
London, United Kingdom 
ORCID: 0000-0001-8495-3500 
Sarah Finer 
Queen Mary University of London 
London, United Kingdom 
s.finer@qmul.ac.uk 
Abstract—Caremaps lack a systematic, easy-to-use graphical 
representation method for care decision points (DPs), which are 
often missing.  This paper addresses this gap by presenting a 
consistent model and representational notation for clinical 
decisions. This paper presents: (1) an analysis of clinical 
decisions that directly impact the path of patient care in the 
contemporary caremap; (2) an extension of the activity diagram 
for caremaps; and (3) the extended TaSC (e-TaSC) model and 
notation for caremaps modelling. Evaluation is done in two case 
studies: gestational diabetes mellitus and trauma caremaps. In 
both case studies, e-TaSC enabled systematic consideration and 
inclusion of clinical DPs leading to clearer, easier-to-follow and 
more comprehensive caremaps than found in the literature.  
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I. INTRODUCTION 
The clinical decision-making landscape is becoming 
increasingly complicated. Patient care involves making 
complex clinical decisions to determine the next steps of care. 
Accurate, personalised information enables clinicians to 
provide precision, rather than just population-based medicine. 
Medical decision-making is often performed under conditions 
of uncertainty within a complex decision threshold model. 
The diagnostic threshold assists the clinician to estimate the 
probability that the patient has the disease, and evaluate 
whether further tests are required. The treatment threshold is 
the point where the probability of disease or its consequences 
is such that treatment is considered beneficial. This threshold 
model in caremaps is often represented similar to the if-then-
else rules and multiple cases of condition-action statements 
similar to the case-switch statement common to software 
programming languages. To ensure maximum utility, all 
outcome options within the decision threshold model of a 
caremap must be represented within the graphical 
visualisation model. Caremaps like that shown in Fig.4 of 
Panzarasa et al [1] provide the clinician with a graphical cue 
representing where a clinical decision needs to be made, while 
failing to provide justification or necessary criteria to assist 
them in easily identifying the best path for their patient. 
Others, like those shown in Fig.1 of Milne et al [2] and Fig.1 
of Saint-Jacques et al [3] present quite granular justification 
for the threshold values or criteria to be considered, but lack 
any visual cue to easily identify or differentiate Decision 
Points (DP) from standard activity nodes. This paper contends 
that integrating DPs into the TaSC caremap model [4] 
combines: (1) a visual cue for clinicians to easily identify 
when a clinical decision needs to be made; and (2) a way to 
identify criteria that enables easy selection of the appropriate 
treatment path based on accumulated evidence-based 
knowledge about the current patient. 
II. CLINICAL DECISIONS 
Clinical decisions that may give rise to DPs in a caremap 
result from six aspects of clinical work identified by 
Richardson et al [5], including: (i) Clinical Evidence: The 
identification and selection of clinical evidence from clinical 
trials and clinical practice guidelines for use in the creation of 
tools, like caremaps, requires decisions regarding how to 
gather the right clinical findings and interpret them soundly; 
(ii) Diagnosis: Diagnostic decisions are made regarding the 
selection and interpretation of diagnostic tests; (iii) Prognosis: 
Prognosis requires decisions of how to anticipate a given 
patient’s likely course; (iv) Therapy: Therapy decisions 
consider how to select treatments that do more good than 
harm; (v) Prevention: Screening and reducing a patient’s risk 
for disease are prevention decisions; and (vi) Education: 
Consideration of how to teach the clinician, patient or 
patient’s family regarding what is needed fall within the remit 
of education decisions. 
III. THE E-TASC MODEL 
Previously, we addressed the lack of a standard for 
caremap structure, content and development process. 
McLachlan et al [4] proposed TaSC. Presented here, the 
extended TaSC model is termed e-TaSC. Structure: 
Caremaps with DPs are presented as flow diagrams. Fig.1 
presents the e-TaSC standardised structural model of the 
caremap with DPs. The elements are inspired by the 
standardised pictorial elements observed in UML and hard 
state chart notations. Content: Similar to TaSC, three main 
content types are captured in e-TaSC; diagnosis, treatment, 
and management/monitoring. As shown in Fig.1, these broad 
content types are related to a set of specific medical activities 
and decisions. Each represents a different caremap level, 
while the activities and decisions are components of the 
caremap. Development: The DPs identified for inclusion in a 
caremap resulted from one of three activities where: (1) a 
divergence was seen in the path of a caremap - i.e. where two 
or more paths were already being represented as possible 
outcomes from an activity node; (2) the clinical practice 
guideline (CPG) identified a scale or set of diagnostic 
thresholds for use in deciding whether or which treatment a 
patient should receive; or (3) where the expert clinicians we 
consulted identified availability of two or more treatments for 
a given test result, symptomology or diagnostic activity. 
 
Fig. 1. The e-TaSC content model for the Caremap with decisions 
IV. CASE STUDIES 
Two case studies were used to evaluate e-TaSC:  
gestational diabetes mellitus (GDM) and helicopter 
emergency medical service (HEMS) trauma care. Both are 
quantitatively evaluated, while the HEMS caremaps was also 
qualitatively evaluated. In each case we develop caremaps 
used in development of Bayesian-based clinical decision 
systems and as part of an approach for elicitation of expert 
knowledge from clinicians. 
A. Case Study 1: GDM Caremap 
Inputs: Inputs were: (a) a clinical practice guideline from 
Barts Health NHS Trust in East London that is currently in use 
for the care of women with diabetes in pregnancy; and, (b) 
clinical expertise and consensus from midwives and 
diabetologists from the same NHS Trust.  
Validation: Validation was performed through 
consultation seeking consensus from three participating 
diabetologists with tertiary care experience treating obstetric 
patients under the CPGs used in the development of the 
caremaps. The GDM Screening and Diagnosis caremap can 
be viewed at:  
http://www.mclachlandigital.com/GDMdx.png 
B. Case Study 2: HEMS Caremaps 
Inputs: Inputs included: (a) a clinical reference textbook 
prescribed for pre-hospital emergency medical training [47]; 
(b) clinical practice guidelines issued by national  or collegiate 
health authorities and intended for use by doctors, paramedics 
and ambulance personnel; (c) current literature on prehospital 
emergency care; and, (d) clinical expertise from a team of pre-
hospital clinicians, paramedics and trauma fellows. The 
SCREAMER caremap can be viewed at:  
http://www.mclachlandigital.com/screamer.png 
The <C>ABCDE caremap can be viewed at:  
http://www.mclachlandigital.com/cabcde.png 
Validation: Initial review and validation was conducted 
with the clinicians. Once there was consensus, extended 
validation was performed through reviews of a small group of 
pre-hospital emergency care clinicians. Some minor 
modifications and ‘fine tuning’ was performed on the basis of 
these reviews that included the addition of clinical factors and 
symptomatology for a number of decision nodes, and the 
addition of a process loop for triaging and treatment in 
situations that presented with multiple casualties. 
V. EVALUATION 
Quantitative: As TaSC was refined and became increasingly 
familiar to those involved, and even as the standard was 
extended with DPs to become e-TaSC, time and resources to 
deliver each caremap significantly reduced.  
Qualitative: The HEMS caremaps were evaluated through 
operation of a survey instrument using a forced-choice Likert 
scale. Survey participants were seven self-identifying 
experienced emergency and trauma clinicians. In each case 
clinicians examined SCREAMER and <C>ABCDE trauma 
caremaps to evaluate whether they possessed qualities similar 
to the CPGs, mnemonic sequence and care processes. Results 
of the survey demonstrate that caremap structure and path, 
when examined independently, were considered to be accurate 
88% (Q1) and 76% (Q2) respectively, while placement, 
purpose and criterion used to describe DPs were 86% (Q3) and 
95% (Q4) accurate. Caremaps were assessed overall to be 
93% accurate when all elements were examined jointly, and 
95% (Q6) easier to use than clinical documentation they were 
based on. This survey of practicing clinicians indicates a high 
degree of accuracy for caremaps developed using the e-TaSC 
approach. While conclusions cannot be generalised due to the 
limited number of participants. 
VI. SUMMARY 
There has been inconsistency in the way DPs are modelled 
and incorporated into caremaps. This paper presented the 
extended TaSC (e-TaSC) model that enables systematic 
consideration of DPs in a caremap that is being modelled.  
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